amitriptyline has been researched along with Pervasive Child Development Disorders in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatti, I | 1 |
| Thome, A | 1 |
| Smith, PO | 1 |
| Cook-Wiens, G | 1 |
| Yeh, HW | 1 |
| Gaffney, GR | 1 |
| Hellings, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Amitriptyline for Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorders[NCT04725383] | Phase 3 | 30 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for amitriptyline and Pervasive Child Development Disorders
| Article | Year |
|---|---|
A retrospective study of amitriptyline in youth with autism spectrum disorders.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Amitriptyline; Atomoxetine Hydrochloride; Child; Child Dev | 2013 |